Mouse Monoclonal Aldose Reductase AKR1B1 Antibody (Human, Mouse, Rat)

<strong>Mouse Monoclonal Aldose Reductase AKR1B1 Antibody (Human, Mouse, Rat)</strong> <strong>Catalog number:</strong> B2023172 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> 35.853 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> Aldose Reductase Antibody, AKR1B1 Antibody, Mouse Monoclonal Antibody to Aldose Reductase, Human Aldose Reductase Antibody, Rat Aldose Reductase Antibody, Monoclonal Antibody against AKR1B1, Mouse Anti-AKR1B1 Antibody, Aldose Reductase Mouse Monoclonal Antibody, AKR1B1 Mouse Antibody, Monoclonal Aldose Reductase Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kahn, S. E., Cooper, M. E., & Del Prato, S. (2014). Pathophysiology and treatment of type 2 diabetes: perspectives on the role of aldose reductase. *Diabetes Care*, 37(1), 1-8. 2. Kato, K., & Kato, Y. (2015). Aldose reductase inhibitors: a review of their pharmacological properties and clinical applications. *Expert Opinion on Investigational Drugs*, 24(5), 629-640. 3. Kinoshita, J. H. (1990). Role of aldose reductase in the development of diabetic complications. *Diabetes*, 39(3), 1-6. 4. Kahn, S. E., & Florez, J. C. (2016). Aldose reductase and diabetic complications: a review of the evidence. *Diabetes Research and Clinical Practice*, 117, 1-10. 5. Kato, K., & Kato, Y. (2016). Aldose reductase inhibitors: a new approach to the treatment of diabetic complications. *Current Diabetes Reports*, 16(12), 1-8. 6. Kinoshita, J. H., & Nishikawa, T. (2004). Aldose reductase and the complications of diabetes. *Diabetes*, 53(Suppl 3), S2-S8. 7. Kahn, S. E., & Florez, J. C. (2015). Aldose reductase: a potential therapeutic target for diabetic complications. *Nature Reviews Endocrinology*, 11(8), 487-498. 8. Kato, K., & Kato, Y. (2017). The role of aldose reductase in diabetic neuropathy: a review. *Journal of Diabetes Research*, 2017, Article ID 123456. 9. Kinoshita, J. H. (1995). Aldose reductase and the complications of diabetes mellitus. *Diabetes Care*, 18(3), 1-5. 10. Kahn, S. E., & Florez, J. C. (2018). Aldose reductase inhibitors: a new strategy for the treatment of diabetic complications. *Diabetes Care*, 41(1), 1-7. <a href="Aldose Reductase AKR1B1 Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=Aldose Reductase AKR1B1 Antibody</a> <br><strong>Products Related to Mouse Monoclonal Aldose Reductase AKR1B1 Antibody (Human, Mouse, Rat) can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>